World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
11782
World Ranking
3719
National Ranking
36

Overview

Mads Hald Andersen is affiliated with Copenhagen University Hospital in Denmark and has a research focus primarily within Medicine and Immunology and Microbiology. Their scholarly contributions extend across several subfields including Immunology, Oncology, Hematology, Genetics, and Molecular Biology. The areas of study most frequently addressed in their work encompass Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cells in Cancer, Immune Cell Function and Interaction, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, and CAR-T Cell Therapy Research.

Andersen has contributed to numerous publications, with recent notable papers including:

  • "A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma" (2021, Nature Medicine)
  • "Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition" (2025, Journal of Hematology & Oncology)
  • "Tumor microenvironment antigens" (2022, Seminars in Immunopathology)
  • "Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade" (2021, Cancer Immunology Research)
  • "Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms" (2021, Frontiers in Oncology)

Frequent co-authors associated with Andersen's work include:

  • Morten Orebo Holmström
  • Inge Marie Svane
  • Evelina Martinenaite
  • Jacob Handlos Grauslund
  • Vibe Skov

Their publications are commonly found in these venues:

  • Frontiers in Immunology
  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Cancers
  • OncoImmunology

Best Publications

  • Cytotoxic T Cells

    Mads Hald Andersen;David Schrama;Per thor Straten;Jürgen C. Becker

  • The effect of short-chain fatty acids on human monocyte-derived dendritic cells

    Claudia Nastasi;Marco Candela;Charlotte Menné Bonefeld;Carsten Geisler

  • Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

    Mads Hald Andersen;Lars Østergaard Pedersen;Jürgen C. Becker;Per thor Straten

  • Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

    Mads Hald Andersen;Lars Ø. Pedersen;Barbara Capeller;Eva-Bettina Bröcker

  • Oncogenic cancer/testis antigens: prime candidates for immunotherapy

    Morten F. Gjerstorff;Mads H. Andersen;Henrik J. Ditzel

  • Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

    Rikke Andersen;Marco Donia;Eva Ellebaek;Troels Holz Borch

  • Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

    Lotte Engell-Noerregaard;Troels Holz Hansen;Mads Hald Andersen;Per thor Straten

  • Immune-suppressive properties of the tumor microenvironment

    Jürgen C. Becker;Mads Hald Andersen;David Schrama;Per thor Straten

  • The universal character of the tumor-associated antigen survivin.

    Mads Hald Andersen;Inge Marie Svane;Jürgen C. Becker;Per thor Straten

  • Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.

    Marion Wobser;Petra Keikavoussi;Volker Kunzmann;Markus Weininger

  • Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

    Eva Ellebaek;Trine Zeeberg Iversen;Niels Junker;Marco Donia;Marco Donia

  • A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

    Unknown

  • Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.

    Mads Hald Andersen;Jordi Espuny Bonfill;Anne Neisig;Gemma Arsequell

  • Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

    Rikke Bæk Sørensen;Sine Reker Hadrup;Inge Marie Svane;Mads Christian Hjortsø

  • Regulators of apoptosis: suitable targets for immune therapy of cancer

    Mads Hald Andersen;Jürgen C. Becker;Per thor Straten

  • Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity

    Marco Donia;Marco Donia;Rikke Andersen;Julie Westerlin Kjeldsen;Paolo Fagone

  • Survivin--a universal tumor antigen.

    M H Andersen;Straten P thor

  • Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin.

    Kerstin Otto;Mads Hald Andersen;Andreas Eggert;Petra Keikavoussi

  • Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

    Trine Zeeberg Iversen;Lotte Engell-Noerregaard;Eva Ellebaek;Rikke Andersen

  • Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

    Claudia Nastasi;Simon Fredholm;Andreas Willerslev-Olsen;Morten Hansen

  • Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

    Eva Ellebaek;Lotte Engell-Noerregaard;Trine Zeeberg Iversen;Thomas Moerch Froesig;Thomas Moerch Froesig

  • Identification of novel survivin-derived CTL epitopes.

    Sine Reker;Anders Meier;Lars Holten-Andersen;Inge Marie Svane

Frequent Co-Authors

Per thor Straten
Per thor Straten University of Copenhagen
Inge Marie Svane
Inge Marie Svane Copenhagen University Hospital
Jürgen C. Becker
Jürgen C. Becker University of Duisburg-Essen
Marco Donia
Marco Donia Copenhagen University Hospital
Morten Hartvig Hansen
Morten Hartvig Hansen University of Southern Denmark
Sine Reker Hadrup
Sine Reker Hadrup Technical University of Denmark
Niels Ødum
Niels Ødum University of Copenhagen
Anders Woetmann
Anders Woetmann University of Copenhagen
Carsten Geisler
Carsten Geisler University of Copenhagen
Eckhart Kämpgen
Eckhart Kämpgen University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students start with a foundational nursing degree before progressing to specialized roles. Programs like the easiest ABSN to get into offer accelerated pathways for individuals transitioning into nursing, helping them build essential skills quickly.

Once a nursing foundation is established, advanced certifications such as acute care NP certification allow practitioners to specialize in critical care environments, complementing their immunology knowledge with hands-on expertise in managing complex conditions.

For those without prior nursing experience, online RN programs for non nurses in Florida provide flexible and accessible routes into the nursing profession. These programs are designed to accommodate diverse backgrounds and offer foundational training relevant to various healthcare fields, including immunology.

Moreover, accelerated programs like accelerated nurse practitioner program help students quickly move into advanced practice roles, where they can integrate immunological principles with clinical expertise. Such pathways support a smooth transition from education to impactful careers in healthcare.

Best Scientists Citing Mads Hald Andersen

Trending Scientists

Recently Published Articles